A Study of ZL-2306 (Niraparib) as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer
Clinical trial NCT03709316 · UNKNOWN
Trial details
- NCT number
- NCT03709316
- Sponsor
- Zai Lab (Shanghai) Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-30
- Primary completion
- 2022-01-29
- Enrollment
- 384
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.